International scientific guidelines: Note for guidance on clinical investigation of medicinal products for the treatment of bipolar disorder

About this guideline

Overseas effective date: 30 Aug 2001

Categories: Clinical efficacy and safety | Nervous system

Access this international scientific guideline

For more information see International scientific guidelines adopted in Australia.

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.